SIFI > About
Vision & History

Established in 1935 by two local pharmacists in Sicily, SIFI started as a venture, specializing in the preparation of ophthalmic products. Since then, research, development, innovation and production have never stopped. Today, SIFI has evolved into an industrial group of companies, consolidating domestic leadership and expanding into international markets worldwide.

A closer look …
SIFI is the only Italian ophthalmic company to feature an full-cycle, integrated business model, including research, development, manufacturing and marketing of pharmaceutical specialties and surgical and medical devices. Cutting-edge innovation, continuous development, a clear understanding of patients and caregivers needs, have shaped an extensive spectrum of eye care products, developed and marketed by our main Italian and foreign branches.
Since June 2015 SIFI is backed by 21 Investimenti, private equity firm founded by Alessandro Benetton to support the company’s international expansion and portfolio development strategy.

S.I.F.I. S.P.A.
Focused on development, production and marketing of pharmaceutical specialties, nutraceuticals and ophthalmic cosmetics, S.I.F.I. S.p.A. is present in 13 countries with a portfolio of over 50 pharmaceutical products. Sifi’s pharmaceutical selection provides treatment options to respond to and treat diverse eyecare conditions. Our portfolio includes steroids, anti-inflammatories, anti-glaucoma, anti-infectives, antibiotics-anti-inflammatory associations, allergy treatments, food supplements (nutraceuticals), artificial tears and re-epithelizing drugs.

SIFI MEDTECH focuses on developing, producing and marketing superior quality surgical and diagnostic products. Specialized in ophthalmology, it provides advanced solutions for cataract surgery and presbyopia with a portfolio including intraocular lens, advanced viscoelastics, surgical disposables , imagery diagnostic instruments and vision testers.

Eyelab is a young and smart pharmaceutical company affiliated to SIFI Group. It was created in 2008 to offer direct distribution of various products developed in SIFI’s 80-year long commitment to treat ophthalmic diseases.

Created in 1998 Oftafarma successfully markets SIFI products in the Romanian market, one of the most dynamic in Eastern Europe, with a focus on innovation in ophthalmology.

Founded in 2007, SIFI’s Central American Laboratories mark the beginning of SIFI Group penetration into one of the most promising emerging markets.

share & tag us with
#history #EyeCare #eyeinfo #health #innovation #business #eye #vision #leadership #pharma
“Vision is the art of seeing what is invisible to others.”
Jonathan Swift

General questions   International Markets       Pharmacovigilance   Vigilance...
Disclosure of Transfers of value    SIFI is a pharmaceutical company committed to fulfilling the needs of its customers, both patients and ophthalmologists.   SIFI strongly...
Manufacturing In the last years SIFI has generated more than 60 patents and secured international alliances worldwide to export its growing portfolio overseas. Our product range spans from state-of-the-art...

On our Social Channels

From our News Center

Starting on March 14th an unprecedented technological innovation will make the Roman monument accessible to all SIFI is pleased to announce the inauguration and opening to the public of "Art...


13 March

SIFI as an example of excellence in Southern Italy and beyond "An example of excellence in the South and beyond"; were some of the words used to describe SIFI,...
Follow Us!